Allos Therapeutics = Done Deal

Allos Therapeutics, Inc. (Ticker: ALTH) just announced that the FTC has cleared its merger with Spectrum Pharmaceuticals, Inc. (Ticker: SPPI). The tender will expire on September 4th and payment should occur promptly thereafter (most likely within a week after the expiration of the tender offer). Allos Therapeutics made up ~ 11% of my portfolio so I'll be a nice little gain (2.24% return or ~ 53% annualized).